• GSK closes $5.1bn Tesaro acquisition pharmaceutical-technology
    January 24, 2019
    GlaxoSmithKline (GSK) has completed its acquisition of US-based biopharmaceutical company Tesaro for an aggregate cash consideration of $5.1bn....
PharmaSources Customer Service